ACCURAY INC(ARAY)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

ACCURAY INC (ARAY) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ARAY at 23.0/100 on a 32-signal composite quality model, placing it at rank #2,739 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include institutional flow (3.6) and revenue growth (12.6), which score below median versus the broader universe. Shareholder dilution risk is elevated at 44.5/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), ACCURAY INC reports quarterly revenue of $100.9M, net income of $-1.9M, free cash flow of $2.0M. Top institutional holders of ARAY by reported 13-F value include TCW GROUP, Neuberger Berman Group, ARMISTICE CAPITAL, based on the most recent SEC filings. ARAY trades on the Nasdaq exchange and files with the SEC under CIK 1138723. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ARAY daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ACCURAY INC directly from SEC EDGAR.